Upexi (UPXI) vs. Its Competitors Critical Analysis

Upexi (NASDAQ:UPXI) is one of 258 public companies in the “Technology Services” industry, but how does it weigh in compared to its competitors? We will compare Upexi to related companies based on the strength of its valuation, profitability, dividends, analyst recommendations, risk, earnings and institutional ownership.

Profitability

This table compares Upexi and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Upexi	264.25%	-30.42%	-16.18%
Upexi Competitors	-415.20%	-646.78%	-16.38%

Risk & Volatility

Upexi has a beta of -0.56, indicating that its share price is 156% less volatile than the S&P 500. Comparatively, Upexi’s competitors have a beta of -15.10, indicating that their average share price is 1,610% less volatile than the S&P 500.

Earnings and Valuation

This table compares Upexi and its competitors top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Upexi	$15.81 million	-$13.68 million	-0.53
Upexi Competitors	$1.28 billion	$24.78 million	-1.00

Upexi’s competitors have higher revenue and earnings than Upexi. Upexi is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Institutional & Insider Ownership

5.7% of Upexi shares are owned by institutional investors. Comparatively, 37.4% of shares of all “Technology Services” companies are owned by institutional investors. 4.4% of Upexi shares are owned by company insiders. Comparatively, 19.8% of shares of all “Technology Services” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a summary of current recommendations and price targets for Upexi and its competitors, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Upexi	1	0	2	0	2.33
Upexi Competitors	1091	2469	5085	284	2.51

Upexi presently has a consensus price target of $10.50, suggesting a potential upside of 251.17%. As a group, “Technology Services” companies have a potential upside of 26.82%. Given Upexi’s higher possible upside, equities analysts plainly believe Upexi is more favorable than its competitors.

Summary

Upexi beats its competitors on 7 of the 13 factors compared.

About Upexi

Upexi, Inc. manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.